Developer docs
API playgroundTry for free, no card

Search company profiles

JPT Peptide Techologies

Full company profile

uuid000btsx

Namestring
JPT Peptide Techologies
Legal namestring
JPT Peptide Technologies GmbH
Websiteurl
jpt.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

JPT Peptide Technologies GmbH is a Berlin-based, privately held peptide manufacturing company founded in 2004 and operating as a subsidiary of BioNTech. The company specializes in synthetic peptide products and services for immunology, immunotherapy, cell therapy, and proteomics research, serving academic institutions, pharmaceutical companies, government agencies (including NIH/NCI), and biotech firms across North America, Europe, and emerging markets. JPT operates a B2B-only model, explicitly excluding private individuals from its customer base, with revenue generated through a mix of fixed-price e-commerce catalog sales (typically US$165–$960 per item) and quote-based custom synthesis and clinical-grade orders. North American sales are supported through a dedicated US phone line and business development email channel.

The company's core technology platform centers on proprietary SPOT ultra-high throughput peptide synthesis, the PepMix peptide pooling system, the QTag absolute quantification method, and high-density PepStar microarrays, all protected by registered trademarks and 20+ years of patented manufacturing know-how. The product portfolio spans overlapping peptide pools (PepMix), positional scanning libraries (PepMaster), antigen discovery pools (SpotMix), reference peptides for targeted proteomics (SpikeTides), clinical-grade peptides and pools for cell therapy and IND-grade applications, custom peptide synthesis at micro to large scale, and a broad modifications portfolio including biotinylation, cyclization, fluorescent labeling, and post-translational modifications. Quality is underpinned by ISO 9001:2015 certification (TÜV Rheinland, annual since 2004) and AEO customs certification, with clinical-grade production meeting regulatory documentation standards for cell therapy and immunotherapy customers.

JPT serves six primary customer segments including cell therapy and immunotherapy developers, immune monitoring and diagnostics researchers, proteomics research laboratories, infectious disease researchers, cancer immunotherapy developers, and autoimmune/allergy researchers. The company is recognized as a major global supplier alongside Miltenyi Biotec, GenScript, and Thermo Fisher, with over 1,000 peer-reviewed publications citing its products. Distribution is direct via an e-commerce platform, formal quote request workflow, and global technical support, with named customers spanning Baylor College of Medicine, Yale, UCL, Charité Berlin, Université de Montréal, University of Cambridge, University of Toronto, and Memorial Sloan Kettering Cancer Center. No revenue is publicly disclosed.

Short descriptiontext

JPT Peptide Technologies GmbH is a Berlin-based, BioNTech-owned manufacturer of synthetic peptides, peptide pools, microarrays, and clinical-grade peptide products serving academic, pharmaceutical, and biotech customers in immunotherapy, cell therapy, immune monitoring, and proteomics research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom peptide synthesis, peptide pools, peptide microarrays, proteomics reagents, immunotherapy peptides
Industry2 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Peptide Synthesis Reagents
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Catalog Peptide Products
TypeOne Time License
Description

Predefined peptide products with fixed prices sold through the online catalog including individual peptides, peptide pools, libraries, and microarrays. Revenue generated through direct online purchasing with prices ranging from approximately $165 to $958 per product item.

jpt.com
2Custom Peptide Synthesis Services
TypeOne Time License
Description

Bespoke peptide manufacturing based on customer specifications including custom purity levels, modifications, lengths, and pooling configurations. Priced through quote requests with 20-30 day payment terms.

jpt.com
3Clinical Grade Peptides
TypeOne Time License
Description

Higher regulatory standard peptides for immunotherapy, cell therapy, and clinical immune monitoring with enhanced quality documentation including batch documentation, CoA according to IND requirements, and optional certified vials.

jpt.com
4T Cell Assay Services
TypeProfessional Services
Description

ELISpot and other T cell assay services including project design assistance, peptide library design, bioinformatics, and professional data analysis and reporting.

jpt.com
5Proteomics Peptides and Kits
TypeOne Time License
Description

Specialized peptides for proteomics applications including SpikeTides reference peptides, SpikeMix pools, and absolute quantified peptides for mass spectrometry-based protein quantification.

jpt.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Pricing details5 tiers
1PepMaster Positional Scanning Peptide Library
ModelUnit PricingBilling cadencePay-as-you-go
Notes

US$3,672.50 per unit (440 µg/pool, crude purity, 96 well microtiter plate format). Limited stock available.

jpt.com
2Catalog Peptides
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual catalog peptides ranging from approximately US$165 to US$960 depending on peptide type and complexity. Examples: Apidaecin IB Peptide US$165.47, Cecropin B US$443.12, DOTA-cyclo(RGDfK) US$958.20.

jpt.com
3Custom Peptide Synthesis
ModelOtherBilling cadencePay-as-you-go
Notes

Custom peptides require quote requests. Pricing depends on peptide length, purity (crude to >95%), modifications, and quantity. Purities available: Crude, >70%, >80%, >90%, >95%.

jpt.com
4Custom PepMix Peptide Pools
ModelOtherBilling cadencePay-as-you-go
Notes

Custom PepMix pools priced via quote request. Quantity options per peptide: 1mg, 2mg, 5mg, 10mg, 15mg, 20mg, 25mg, 50mg. Purity options: Crude, >70%, >80%, >90%, >95%.

jpt.com
5SpikeTides TQL PLUS
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Absolute quantified peptides: 10-150nmol amount, 1-10nmol/aliquot, >95% purity, isotopical purity 99%. Priced via quote request.

jpt.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1PepMix™
Description

Antigen-spanning peptide pools for T-cell stimulation and immune monitoring

jpt.com
+11 more records
Core offering1 text field

JPT Peptide Technologies manufactures and sells specialty peptide-based reagents and synthesis services for immunotherapy, immunology, and proteomics research. The portfolio spans PepMix peptide pools, PepStar peptide microarrays, PepTrack and PepMaster peptide libraries, SpikeTides stable-isotope-labeled reference peptides, SpotMix antigen discovery pools, and clinical-grade peptides, supported by custom peptide synthesis with 25+ modifications. The company serves pharmaceutical/biotech companies, research institutions, and universities worldwide from its ISO 9001:2015-certified Berlin laboratories, with explicit policy against serving private individuals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 94% response rate in virus-specific T cell therapy using Clinical Grade PepMix pools in transplant patients
+3 more records
Product overview1 text field

JPT Peptide Technologies is a specialized peptide manufacturing company offering a comprehensive portfolio of peptide-based products and services for immunology, cell therapy, vaccine development, and proteomics research. The company's offerings span core product lines including PepMix™ Peptide Pools (overlapping peptide pools for T-cell stimulation), PepStar™ Peptide Microarrays (high-density arrays for antibody profiling), PepTrack™ Peptide Libraries (custom libraries for epitope discovery), and SpikeTides™ TQL/TQL PLUS (absolute quantified peptides for proteomics). Additional key products include the PepMaster™ Positional Scanning Peptide Library, SpotMix™ Antigen Discovery Pools for rapid screening, and Clinical Peptides & Pools for immunotherapy applications. The company also provides Custom Peptide Synthesis services at various scales and purities, comprehensive Peptide Modifications (biotinylation, cyclization, fluorescent labeling, etc.), SpikeMix™ Reference Peptide Pools for targeted proteomics, and T Cell Assay Services including ELISpot. JPT operates under ISO 9001:2015 certification and is headquartered in Berlin, Germany.

Product and service12 records
1PepMix Peptide Pools
CategoryPeptide Pools
Description

Overlapping peptide pools covering viral or tumor antigens for antigen-specific T-cell stimulation in T cell assays, ELISpot, cytokine staining, cell-mediated cytotoxicity, proliferation assays, dendritic cell pulsing, and immune monitoring, sold as catalog product lines including PepMix for Infectious Disease Antigens, PepMix for Tumor Associated Antigens, PepMix Ultra Pools, PepMix Collections, and Pan Select PepMix.

2PepStar Peptide Microarrays
CategoryPeptide Microarrays
Description

High-density peptide microarrays for large-scale antibody profiling, epitope mapping, and serological screening in infectious disease, cancer, and autoimmune research.

3PepTrack Peptide Libraries
CategoryPeptide Libraries
Description

Customized peptide libraries with flexible layout and specifications optimized for deep T-cell epitope discovery using ELISpot and intracellular cytokine staining assays.

4SpikeTides TQL / TQL PLUS Absolute Quantified Peptides
CategoryProteomics Reagents
Description

Absolute quantified peptides incorporating the proprietary QTag technology for accurate protein quantification in mass spectrometry-based targeted proteomics workflows (SRM, MRM, PRM), supplied as SpikeTides TQL and SpikeTides TQL PLUS variants.

5PepMaster Positional Scanning Peptide Library
CategoryPeptide Libraries
Description

Positional scanning peptide library containing 181 different peptide mixtures used to identify stimulating peptides for T-cell clones, where each mixture contains 9mer peptides with a single fixed amino acid position.

6SpotMix Antigen Discovery Pools
CategoryAntigen Discovery Reagents
Description

Small-scale overlapping peptide pools synthesized using JPT's proprietary ultra-high throughput SPOT technology for antigen target discovery, T-cell epitope discovery, and biological screening.

7Clinical Peptides & Pools
CategoryClinical-Grade Peptides
Description

Clinical-grade peptides and PepMix pools produced under strict quality regulations for immunotherapy, cell therapy, clinical immune monitoring, and vaccine development, available as ISO PLUS or Clinical Grade specifications with full batch documentation and IND-ready Certificates of Analysis.

8Custom Peptide Synthesis
CategoryCustom Synthesis Services
Description

Tailored peptide synthesis service offering micro-scale (10-50 nmol), intermediate (1-100 mg), and large-scale (>1 g) synthesis with customizable purity from crude to >95%, 25+ specialty modifications, and quantity-tiered options.

9SpikeMix Reference Peptide Pools
CategoryProteomics Reagents
Description

Stable-isotope-labeled reference peptide pools enabling relative protein quantification in mass spectrometry-based targeted proteomics assays.

10PepSpots Peptides on Cellulose
CategoryPeptide Arrays
Description

Peptide arrays synthesized directly on cellulose membrane supports for high-throughput screening and epitope mapping applications.

11T Cell Assay Services
CategoryBioassay Services
Description

Comprehensive T cell assay services including ELISpot for immunogenicity testing, T cell epitope discovery, neo-epitope qualification, and antigen discovery with full project support from design through bioinformatics and professional data analysis and reporting.

12Immune Monitoring Services
CategoryBioassay Services
Description

Comprehensive immune monitoring services for cellular and humoral immune response profiling to support clinical trials and immunotherapy development.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

JPT Peptide Technologies is a subsidiary of BioNTech. The privacy policy states 'This may involve the processing of personal data by other group companies and providers on behalf of BioNTech.' The partnership represents a significant strategic alignment within the BioNTech group of companies, indicating close integration in operations and potential synergies in immunotherapy and vaccine development.

Strategic tierMinorTypeOthers
Description

Annual audit and certification partner for ISO 9001:2015 quality management system. TÜV Rheinland conducts yearly review and certification of JPT's quality management system.

3CleverReach GmbH & Co. KG
Strategic tierMinorTypeOthers
Description

Email service provider for newsletter creation and distribution. JPT uses CleverReach to create and send newsletters to customers and subscribers. A data processing agreement is in place ensuring CleverReach does not use customer data for its own purposes.

jpt.com
Strategic tierMinorTypeOthers
Description

Payment service provider for credit card processing in the online shop. Credit card information is entered in store and forwarded to Unzer for processing, ensuring payment data is not stored at JPT's webshop.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative development of ABRF cross-species SpikeMix Peptide Pool with ABRF standard proteomic research group (sPRG). The resulting product was qualified in more than 52 proteomics labs around the globe, demonstrating successful academic-industry partnership for proteomics standards development.

6US Government Agencies
Strategic tierCoreTypeStrategic or Co-development Partner
Description

JPT products used in NIH and other government-funded research programs. National Cancer Institute researchers use JPT peptides for clinical trial evaluations. Baylor College of Medicine, which receives government funding, collaborates on cell therapy development with JPT products.

jpt.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1AAPPTec
TypeEmerging player
Description

AAPPTec is a niche peptide synthesis equipment, reagents, and custom synthesis provider. It competes with JPT in custom peptide services and adjacent reagents, though with a smaller catalog scale focused on specialist research customers.

TypeDirect peer
Description

GenScript offers custom peptide synthesis alongside gene synthesis and cell therapy services. It is explicitly identified in JPT's market data as a key global peptide supplier and competes head-to-head in custom synthesis and T-cell reagent pools.

TypeDirect peer
Description

Cambridge Research Biochemicals is a UK-based custom peptide synthesis and antibody specialist with overlapping customer types (academic and pharma research). It competes with JPT in custom peptides, modifications, and conjugated peptide offerings.

TypeDirect peer
Description

Bachem is a publicly listed specialist peptide manufacturer serving pharmaceutical and clinical customers with custom synthesis and GMP/clinical-grade peptides. It is a direct comparable in scale and regulatory capability to JPT's clinical-grade production line.

TypeDirect peer
Description

PolyPeptide Group is a publicly listed GMP peptide manufacturer serving pharma customers. It competes with JPT in clinical- and commercial-grade peptide supply, particularly for therapeutic peptide and conjugate applications.

TypeBroad incumbent
Description

Thermo Fisher is the largest life-science tools company and is explicitly cited in JPT's market data as a top global peptide-pool competitor. It competes via its Pierce, PeproTech, and mass spectrometry reagent lines and can bundle peptides into broader procurement contracts.

7Vivitide
TypeDirect peer
Description

Vivitide (formerly Peptides International) is a US-based specialty peptide manufacturer with catalog, custom, and GMP capabilities. It competes directly with JPT in custom peptide synthesis and clinical-grade peptide supply.

TypeDirect peer
Description

Miltenyi Biotec is a leading cell therapy and immunology reagent provider, explicitly named alongside JPT as a key global peptide-pool supplier. It overlaps heavily with JPT's PepMix products for T-cell stimulation and clinical immune monitoring.

TypeBroad incumbent
Description

Bio-Techne (including its ProteinSimple and R&D Systems brands) is a diversified life-science tools provider with peptide reagents, proteomics kits, and immunology assays. It overlaps with JPT across proteomics and immune-monitoring product lines as part of a much broader portfolio.

TypeEmerging player
Description

ProteoGenix is a French biotech offering custom peptide synthesis and antibody services with growing focus on therapeutic peptide and protein production. It is a smaller-scale emerging competitor overlapping with JPT's custom and therapeutic-grade peptide work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JPT Peptide Techologies

Peptide Synthesis Reagentsjpt.com

JPT Peptide Technologies GmbH is a Berlin-based, BioNTech-owned manufacturer of synthetic peptides, peptide pools, microarrays, and clinical-grade peptide products serving academic, pharmaceutical, and biotech customers in immunotherapy, cell therapy, immune monitoring, and proteomics research.

What JPT Peptide Techologies does

JPT Peptide Technologies GmbH is a Berlin-based, privately held peptide manufacturing company founded in 2004 and operating as a subsidiary of BioNTech. The company specializes in synthetic peptide products and services for immunology, immunotherapy, cell therapy, and proteomics research, serving academic institutions, pharmaceutical companies, government agencies (including NIH/NCI), and biotech firms across North America, Europe, and emerging markets. JPT operates a B2B-only model, explicitly excluding private individuals from its customer base, with revenue generated through a mix of fixed-price e-commerce catalog sales (typically US$165–$960 per item) and quote-based custom synthesis and clinical-grade orders. North American sales are supported through a dedicated US phone line and business development email channel.

The company's core technology platform centers on proprietary SPOT ultra-high throughput peptide synthesis, the PepMix peptide pooling system, the QTag absolute quantification method, and high-density PepStar microarrays, all protected by registered trademarks and 20+ years of patented manufacturing know-how. The product portfolio spans overlapping peptide pools (PepMix), positional scanning libraries (PepMaster), antigen discovery pools (SpotMix), reference peptides for targeted proteomics (SpikeTides), clinical-grade peptides and pools for cell therapy and IND-grade applications, custom peptide synthesis at micro to large scale, and a broad modifications portfolio including biotinylation, cyclization, fluorescent labeling, and post-translational modifications. Quality is underpinned by ISO 9001:2015 certification (TÜV Rheinland, annual since 2004) and AEO customs certification, with clinical-grade production meeting regulatory documentation standards for cell therapy and immunotherapy customers.

JPT serves six primary customer segments including cell therapy and immunotherapy developers, immune monitoring and diagnostics researchers, proteomics research laboratories, infectious disease researchers, cancer immunotherapy developers, and autoimmune/allergy researchers. The company is recognized as a major global supplier alongside Miltenyi Biotec, GenScript, and Thermo Fisher, with over 1,000 peer-reviewed publications citing its products. Distribution is direct via an e-commerce platform, formal quote request workflow, and global technical support, with named customers spanning Baylor College of Medicine, Yale, UCL, Charité Berlin, Université de Montréal, University of Cambridge, University of Toronto, and Memorial Sloan Kettering Cancer Center. No revenue is publicly disclosed.

JPT Peptide Techologies firmographics

Firmographics
Name
JPT Peptide Techologies
Legal name
JPT Peptide Technologies GmbH
Website
https://jpt.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
JPT Peptide Technologies GmbH is a Berlin-based, BioNTech-owned manufacturer of synthetic peptides, peptide pools, microarrays, and clinical-grade peptide products serving academic, pharmaceutical, and biotech customers in immunotherapy, cell therapy, immune monitoring, and proteomics research.
Ownership category
akta.pro rank

JPT Peptide Techologies industry classification

Industry
Product category
Peptide Synthesis Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)

Keywords

  • Custom peptide synthesis
  • Peptide pools
  • Peptide microarrays
  • Proteomics reagents
  • Immunotherapy peptides

Where JPT Peptide Techologies is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

JPT Peptide Techologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Catalog Peptide Products: Predefined peptide products with fixed prices sold through the online catalog including individual peptides, peptide pools, libraries, and microarrays. Revenue generated through direct online purchasing with prices ranging from approximately $165 to $958 per product item.
  2. Custom Peptide Synthesis Services: Bespoke peptide manufacturing based on customer specifications including custom purity levels, modifications, lengths, and pooling configurations. Priced through quote requests with 20-30 day payment terms.
  3. Clinical Grade Peptides: Higher regulatory standard peptides for immunotherapy, cell therapy, and clinical immune monitoring with enhanced quality documentation including batch documentation, CoA according to IND requirements, and optional certified vials.
  4. T Cell Assay Services: ELISpot and other T cell assay services including project design assistance, peptide library design, bioinformatics, and professional data analysis and reporting.
  5. Proteomics Peptides and Kits: Specialized peptides for proteomics applications including SpikeTides reference peptides, SpikeMix pools, and absolute quantified peptides for mass spectrometry-based protein quantification.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPepMaster Positional Scanning Peptide Library
Unit PricingPay-as-you-goCatalog Peptides
OtherPay-as-you-goCustom Peptide Synthesis
OtherPay-as-you-goCustom PepMix Peptide Pools
Unit PricingPay-as-you-goSpikeTides TQL PLUS

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

JPT Peptide Techologies product offering

Product offering

Core offering

JPT Peptide Technologies manufactures and sells specialty peptide-based reagents and synthesis services for immunotherapy, immunology, and proteomics research. The portfolio spans PepMix peptide pools, PepStar peptide microarrays, PepTrack and PepMaster peptide libraries, SpikeTides stable-isotope-labeled reference peptides, SpotMix antigen discovery pools, and clinical-grade peptides, supported by custom peptide synthesis with 25+ modifications. The company serves pharmaceutical/biotech companies, research institutions, and universities worldwide from its ISO 9001:2015-certified Berlin laboratories, with explicit policy against serving private individuals.

Product overview

JPT Peptide Technologies is a specialized peptide manufacturing company offering a comprehensive portfolio of peptide-based products and services for immunology, cell therapy, vaccine development, and proteomics research. The company's offerings span core product lines including PepMix™ Peptide Pools (overlapping peptide pools for T-cell stimulation), PepStar™ Peptide Microarrays (high-density arrays for antibody profiling), PepTrack™ Peptide Libraries (custom libraries for epitope discovery), and SpikeTides™ TQL/TQL PLUS (absolute quantified peptides for proteomics). Additional key products include the PepMaster™ Positional Scanning Peptide Library, SpotMix™ Antigen Discovery Pools for rapid screening, and Clinical Peptides & Pools for immunotherapy applications. The company also provides Custom Peptide Synthesis services at various scales and purities, comprehensive Peptide Modifications (biotinylation, cyclization, fluorescent labeling, etc.), SpikeMix™ Reference Peptide Pools for targeted proteomics, and T Cell Assay Services including ELISpot. JPT operates under ISO 9001:2015 certification and is headquartered in Berlin, Germany.

Differentiator

Problem solved

Functional benefit

Brands

  • PepMix™: Antigen-spanning peptide pools for T-cell stimulation and immune monitoring
  • PepStar™
  • PepTrack™
  • SpotMix™
  • SpikeTides™
  • SpikeMix™
  • PepMaster™
  • BioTides™
  • PepSequencer
  • PepSup™
  • PepSpots™
  • Pan Select PepMix™

Products and services

  • PepMix Peptide Pools Overlapping peptide pools covering viral or tumor antigens for antigen-specific T-cell stimulation in T cell assays, ELISpot, cytokine staining, cell-mediated cytotoxicity, proliferation assays, dendritic cell pulsing, and immune monitoring, sold as catalog product lines including PepMix for Infectious Disease Antigens, PepMix for Tumor Associated Antigens, PepMix Ultra Pools, PepMix Collections, and Pan Select PepMix.
  • PepStar Peptide Microarrays High-density peptide microarrays for large-scale antibody profiling, epitope mapping, and serological screening in infectious disease, cancer, and autoimmune research.
  • PepTrack Peptide Libraries Customized peptide libraries with flexible layout and specifications optimized for deep T-cell epitope discovery using ELISpot and intracellular cytokine staining assays.
  • SpikeTides TQL / TQL PLUS Absolute Quantified Peptides Absolute quantified peptides incorporating the proprietary QTag technology for accurate protein quantification in mass spectrometry-based targeted proteomics workflows (SRM, MRM, PRM), supplied as SpikeTides TQL and SpikeTides TQL PLUS variants.
  • PepMaster Positional Scanning Peptide Library Positional scanning peptide library containing 181 different peptide mixtures used to identify stimulating peptides for T-cell clones, where each mixture contains 9mer peptides with a single fixed amino acid position.
  • SpotMix Antigen Discovery Pools Small-scale overlapping peptide pools synthesized using JPT's proprietary ultra-high throughput SPOT technology for antigen target discovery, T-cell epitope discovery, and biological screening.
  • Clinical Peptides & Pools Clinical-grade peptides and PepMix pools produced under strict quality regulations for immunotherapy, cell therapy, clinical immune monitoring, and vaccine development, available as ISO PLUS or Clinical Grade specifications with full batch documentation and IND-ready Certificates of Analysis.
  • Custom Peptide Synthesis Tailored peptide synthesis service offering micro-scale (10-50 nmol), intermediate (1-100 mg), and large-scale (>1 g) synthesis with customizable purity from crude to >95%, 25+ specialty modifications, and quantity-tiered options.
  • SpikeMix Reference Peptide Pools Stable-isotope-labeled reference peptide pools enabling relative protein quantification in mass spectrometry-based targeted proteomics assays.
  • PepSpots Peptides on Cellulose Peptide arrays synthesized directly on cellulose membrane supports for high-throughput screening and epitope mapping applications.
  • T Cell Assay Services Comprehensive T cell assay services including ELISpot for immunogenicity testing, T cell epitope discovery, neo-epitope qualification, and antigen discovery with full project support from design through bioinformatics and professional data analysis and reporting.
  • Immune Monitoring Services Comprehensive immune monitoring services for cellular and humoral immune response profiling to support clinical trials and immunotherapy development.

Quantifiable outcome

  • 94% response rate in virus-specific T cell therapy using Clinical Grade PepMix pools in transplant patients
  • +3 more outcomes

Companies that use JPT Peptide Techologies

Customer profile

Named customers10 records

Segments6 records

Ideal customer profiles3 records

JPT Peptide Techologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

JPT Peptide Techologies partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • BioNTechcoreStrategic or Co-development PartnerJPT Peptide Technologies is a subsidiary of BioNTech. The privacy policy states 'This may involve the processing of personal data by other group companies and providers on behalf of BioNTech.' The partnership represents a significant strategic alignment within the BioNTech group of companies, indicating close integration in operations and potential synergies in immunotherapy and vaccine development.
  • TÜV RheinlandminorOthersAnnual audit and certification partner for ISO 9001:2015 quality management system. TÜV Rheinland conducts yearly review and certification of JPT's quality management system.
  • CleverReach GmbH & Co. KGminorOthersEmail service provider for newsletter creation and distribution. JPT uses CleverReach to create and send newsletters to customers and subscribers. A data processing agreement is in place ensuring CleverReach does not use customer data for its own purposes.
  • Unzer GmbHminorOthersPayment service provider for credit card processing in the online shop. Credit card information is entered in store and forwarded to Unzer for processing, ensuring payment data is not stored at JPT's webshop.
  • Association of Biomolecular Resource Facilities (ABRF)coreStrategic or Co-development PartnerCollaborative development of ABRF cross-species SpikeMix Peptide Pool with ABRF standard proteomic research group (sPRG). The resulting product was qualified in more than 52 proteomics labs around the globe, demonstrating successful academic-industry partnership for proteomics standards development.
  • US Government AgenciescoreStrategic or Co-development PartnerJPT products used in NIH and other government-funded research programs. National Cancer Institute researchers use JPT peptides for clinical trial evaluations. Baylor College of Medicine, which receives government funding, collaborates on cell therapy development with JPT products.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

JPT Peptide Techologies competitors and assessment

Company assessment

Emerging players

  • AAPPTec: AAPPTec is a niche peptide synthesis equipment, reagents, and custom synthesis provider. It competes with JPT in custom peptide services and adjacent reagents, though with a smaller catalog scale focused on specialist research customers.
  • ProteoGenix: ProteoGenix is a French biotech offering custom peptide synthesis and antibody services with growing focus on therapeutic peptide and protein production. It is a smaller-scale emerging competitor overlapping with JPT's custom and therapeutic-grade peptide work.

Direct peers

  • GenScript: GenScript offers custom peptide synthesis alongside gene synthesis and cell therapy services. It is explicitly identified in JPT's market data as a key global peptide supplier and competes head-to-head in custom synthesis and T-cell reagent pools.
  • Cambridge Research Biochemicals: Cambridge Research Biochemicals is a UK-based custom peptide synthesis and antibody specialist with overlapping customer types (academic and pharma research). It competes with JPT in custom peptides, modifications, and conjugated peptide offerings.
  • Bachem: Bachem is a publicly listed specialist peptide manufacturer serving pharmaceutical and clinical customers with custom synthesis and GMP/clinical-grade peptides. It is a direct comparable in scale and regulatory capability to JPT's clinical-grade production line.
  • PolyPeptide Group: PolyPeptide Group is a publicly listed GMP peptide manufacturer serving pharma customers. It competes with JPT in clinical- and commercial-grade peptide supply, particularly for therapeutic peptide and conjugate applications.
  • Vivitide: Vivitide (formerly Peptides International) is a US-based specialty peptide manufacturer with catalog, custom, and GMP capabilities. It competes directly with JPT in custom peptide synthesis and clinical-grade peptide supply.
  • Miltenyi Biotec: Miltenyi Biotec is a leading cell therapy and immunology reagent provider, explicitly named alongside JPT as a key global peptide-pool supplier. It overlaps heavily with JPT's PepMix products for T-cell stimulation and clinical immune monitoring.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher is the largest life-science tools company and is explicitly cited in JPT's market data as a top global peptide-pool competitor. It competes via its Pierce, PeproTech, and mass spectrometry reagent lines and can bundle peptides into broader procurement contracts.
  • Bio-Techne: Bio-Techne (including its ProteinSimple and R&D Systems brands) is a diversified life-science tools provider with peptide reagents, proteomics kits, and immunology assays. It overlaps with JPT across proteomics and immune-monitoring product lines as part of a much broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

JPT Peptide Techologies social profiles

Digital presence

JPT Peptide Techologies compliance and trust

Trust signal

Compliance1 record

JPT Peptide Techologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JPT Peptide Techologies leadership team

Management profile

Number of profiles

JPT Peptide Techologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JPT Peptide Techologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JPT Peptide Techologies

What does JPT Peptide Techologies do?

JPT Peptide Technologies manufactures and sells specialty peptide-based reagents and synthesis services for immunotherapy, immunology, and proteomics research. The portfolio spans PepMix peptide pools, PepStar peptide microarrays, PepTrack and PepMaster peptide libraries, SpikeTides stable-isotope-labeled reference peptides, SpotMix antigen discovery pools, and clinical-grade peptides, supported by custom peptide synthesis with 25+ modifications. The company serves pharmaceutical/biotech companies, research institutions, and universities worldwide from its ISO 9001:2015-certified Berlin laboratories, with explicit policy against serving private individuals.

Is JPT Peptide Techologies a public or private company?

JPT Peptide Techologies is a private company. It is classified as corporate owned and is currently operating.

When was JPT Peptide Techologies founded?

JPT Peptide Techologies was founded in 2004. It employs 51 to 100 people.

Where is JPT Peptide Techologies based?

JPT Peptide Techologies is headquartered in Berlin, Germany, in the Europe region.

How does JPT Peptide Techologies make money?

Five revenue lines are on record. Catalog Peptide Products are the primary driver. The others are custom Peptide Synthesis Services, clinical Grade Peptides, T Cell Assay Services and proteomics Peptides and Kits.

Who are JPT Peptide Techologies's main competitors?

Emerging players on record are AAPPTec and ProteoGenix. Direct peers are GenScript, Cambridge Research Biochemicals, Bachem, PolyPeptide Group, Vivitide and Miltenyi Biotec. Broad incumbents are Thermo Fisher Scientific and Bio-Techne.

Does JPT Peptide Techologies have an API?

No public API is recorded for JPT Peptide Techologies.

What industry is JPT Peptide Techologies in?

JPT Peptide Techologies's product category is Peptide Synthesis Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IndexBoxReport - IndexBox - Prices, Size, Forecast, and CompaniesThis is a market research report analyzing the India Myc Antigen Peptide Pools market, estimated at INR 75–110 crore (approximately USD 9–13 million) in 2025, with high import dependence exceeding 70% of total demand. The market is driven primarily by tuberculosis vaccine R&D and immune monitoring applications, with growth projected at 9–12% CAGR through 2035. The competitive landscape is shaped by global suppliers including Miltenyi Biotec, JPT Peptide Technologies, and GenScript, alongside emerging domestic CDMOs such as USV Private Limited.IndexBoxReport - IndexBox - Prices, Size, Forecast, and CompaniesIndexBox published a market analysis report on Brazil's Myc Antigen Peptide Pools market, finding that over 90% of domestic consumption is met by imports from the United States, Germany, and China due to the absence of domestic GMP-grade synthesis capacity. The report projects market volume growth of 7-9% CAGR from 2026 to 2035, driven by Brazil's high tuberculosis burden and active participation in global TB vaccine and immunodiagnostic trials, with total demand expected to approximately double by 2035. Key suppliers identified include Miltenyi Biotec, Thermo Fisher Scientific, JPT Peptide Technologies, and GenScript, while domestic buyers span academic research institutes, CROs, and biopharma firms including Instituto Butantan and Eurofarma.IndexBoxReport - IndexBox - Prices, Size, Forecast, and CompaniesIndexBox published a market research report on the Germany Myc Antigen Peptide Pools market, estimating it will grow at an 8-12% CAGR from 2026 to 2035, with GMP-grade segments outpacing research-grade (10-14% vs 6-9% CAGR). The report identifies Germany's concentrated biopharma ecosystem and EU In Vitro Diagnostic Regulation as structural demand drivers, profiling major suppliers including Miltenyi Biotec, JPT Peptide Technologies, Bachem, CordenPharma, and Thermo Fisher Scientific. The market is moderately concentrated, with the top 5-6 suppliers accounting for an estimated 70-80% of market value.openPR.comPeptide Microarray Assay Service Industry Market Report 2022 : Detail Research on Global Growth Size, Insights and Forecast: JPT, LC Sciences, Creative ProteomicsStratagem Market Insights published a market research report forecasting the global Peptide Microarray Assay Service industry from 2022 to 2030. The study analyzes market size, growth drivers, and competitive landscapes for key players including JPT, LC Sciences, and Creative Proteomics. It provides detailed segmentation by product type, application, and region to guide stakeholder investment decisions.GlobeNewswireJPT Launches Broad Spectrum of COVID-19 Peptide Tools for Immune Monitoring, Vaccine & Diagnostics DevelopmentJPT Peptide Technologies launched ready-to-use peptide tools for SARS-CoV-2 immune monitoring, including a high-content peptide microarray and PepMix pools. The products aim to support vaccine, immunotherapy, and diagnostics development by enabling epitope-resolved immune response analysis.GlobeNewswireJPT Launches Broad Spectrum of COVID-19 Peptide Tools for Immune Monitoring, Vaccine & Diagnostics DevelopmentJPT Peptide Technologies launched ready-to-use peptide tools for SARS-CoV-2 immune monitoring, including a high-content peptide microarray and PepMix peptide pools. The products aim to support vaccine, immunotherapy, and diagnostics development by enabling epitope-resolved immune response analysis.GlobeNewswireAd hoc: Jerini AG: Jerini AG Reaches Agreement to Sell JPT Peptide Technologies GmbH to TheraCode GmbHJerini AG agreed to sell its subsidiary JPT Peptide Technologies GmbH to TheraCode GmbH, a BioNTech subsidiary, for approximately €5 million in cash. The sale supports Jerini's strategic decision to divest non-strategic businesses and focus on its core Firazyr business.GlobeNewswireJPT Launches 'PepTrack(tm) -- Peptide Library Technologies' for T-cell Assays in Vaccine DevelopmentJPT Peptide Technologies launched PepTrack, a peptide library technology for T-cell assays, with four delivery options. The product is produced under DIN ISO 9001:2008 and Good Clinical Laboratory Practices, and JPT increased its production capacity to over 2 million peptides per year.